Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000413532 | SCV000491475 | pathogenic | not provided | 2022-07-28 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31607746, 26846447, 28554554, 32703465, 26100331, 25609763, 25512093, 35899263, 33060286) |
Undiagnosed Diseases Network, |
RCV000625972 | SCV000746573 | pathogenic | Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures | 2018-03-16 | criteria provided, single submitter | clinical testing | The c.2327C>T variant in the DYNC1H1 gene has been reported previously (PMCID:4742772). The patient and his 2 similarly affected identical twin brothers were found to carry the variant. The father was mosaic for this variant with mild symptoms. |
Labcorp Genetics |
RCV000809340 | SCV000949489 | pathogenic | Charcot-Marie-Tooth disease axonal type 2O | 2023-08-28 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DYNC1H1 protein function. ClinVar contains an entry for this variant (Variation ID: 372934). This missense change has been observed in individual(s) with lower extremity predominant spinal muscular atrophy (PMID: 26846447, 28554554). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 776 of the DYNC1H1 protein (p.Pro776Leu). |
Institute of Medical Genetics and Applied Genomics, |
RCV000413532 | SCV001447473 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV000625972 | SCV002061416 | pathogenic | Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures | 2021-06-24 | criteria provided, single submitter | clinical testing | PS2, PP2, PP3, PM1, PM2, PS4_Moderate |
Revvity Omics, |
RCV000413532 | SCV003823356 | pathogenic | not provided | 2022-11-28 | criteria provided, single submitter | clinical testing | |
3billion | RCV000625972 | SCV003841803 | pathogenic | Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures | 2023-02-23 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. Missense changes are a common disease-causing mechanism. Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000372934). The variant has been previously reported as de novo in a similarly affected individual (PMID: 26846447). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. |
Ce |
RCV000413532 | SCV005330744 | pathogenic | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | DYNC1H1: PS2:Very Strong, PM2, PS4:Moderate, PP2 |
Département de Neurologie, |
RCV000625972 | SCV003836498 | likely pathogenic | Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures | 2023-02-24 | no assertion criteria provided | clinical testing |